Pharmaceutical Sterility Testing Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

Market Highlights

According to MRFR analysis, the global Pharmaceutical Sterility Testing Market size is expected to register a CAGR of 6.10% from 2020 to 2030 and hold a value of USD 900 million by 2030.

Sterility can be defined as the non-appearance of viable microorganisms, dust, fibers, foreign particles, and other biological agents. Pharmaceutical sterility testing is performed on a wide range of biological medicinal products, including blood products, vaccines, biotechnology products, cell products, and tissue products, in accordance with WHO sterility requirements. Sterility testing is carried out by companies such as pharmaceutical companies, biotechnology companies, and medical device manufacturers to assess process control, raw material quality, and product validity.

The industry players focus on technological developments to dominate the global Pharmaceutical Sterility Testing Market. In addition, the key players are involved in new product launches, acquisitions, and joint ventures to augment their market positions. For instance, in July 2020, Neogen Corporation (US) has launched Soleris, an advanced test system that can rapidly detect a wide variety of microorganisms in a fraction of the time.

Key Players

Some of the Pharmaceutical Sterility Testing Market Players are.

§  Merck KGaA (Germany),

§  Rapid Micro Biosystems (US),

§  Sartorius AG (Germany),

§  Solvias AG (Switzerland),

§  SGS SA (Switzerland),

§  Boston Analytical (US),

§  bioMérieux, Inc. (France),

§  Charles River Laboratories International, Inc. (US),

§  Thermo Fisher Scientific, Inc. (US),

§  Pace Analytical Services, LLC (US),

§  Toxikon, Inc. (US),

§  Sotera Health (US),

§  Pacific Biolabs Inc. (US),

§  STRERIS Corporation (US),

§  WuXi AppTec (China).

Regional Analysis

North America is anticipated to dominate the global pharmaceutical sterility testing market, owing to the presence of several key players in the region and the rise in R&D investments by public and private players in the healthcare sector. Moreover, the increase in the number of pipeline products and the launch of advanced drugs based on the biopharmaceutical that requires unique pharmaceutical sterility testing processes are also propelling the market growth.

The European pharmaceutical sterility testing market has been categorized into Germany, France, the UK, Italy, Spain, and the rest of Europe. Increasing government initiatives and extensive availability of research grants in the European countries are expected to propel the growth of the pharmaceutical sterility testing market in the region. Furthermore, the presence of outsourcing companies for pharmaceutical sterility testing is also supporting the growth of the pharmaceutical sterility testing market.

Asia-Pacific is anticipated to be the fastest-growing regional market over the forecast period due to the increasing harmonization of the regulatory standards with the International Council for Harmonisation (ICH) standards in developing nations, technological advances, and increasing investment in healthcare infrastructure. In addition, growing investment by governments from the China and India for offering cost-effective medications is providing lucrative opportunities for the growth of the pharmaceutical sterility testing market over the forecast period.

 In the Middle East, the UAE is the largest market due to the healthcare industry's development. Developing countries such as Argentina, Brazil, and Colombia, among others in Latin America, are also key contributors to the growth of the pharmaceutical sterility testing market insights.

Segmentation

The global sterility testing microbiology market has been segmented based on sample, product type, type, test type, and end user. By sample, the market has been segregated into sterile drugs, medical devices, and biologics. The sterile drugs segment is expected to witness high growth in 2020, Owing to the high adoption of several techniques adopted for product safety across the globe.

           ·          Based on product type, the global pharmaceutical sterility testing market has been classified into instruments, kits & reagents, and services. Kits & reagents held the largest segment share in 2020, owing to the repetitive purchase of these products by end users all around the world. In addition, cost efficiency and ease of use are related to the product.

           ·          Based on type, the global pharmaceutical sterility testing market has been classified into in-house and outsourcing.

           ·          Based on test type, the global pharmaceutical sterility testing market has been classified into sterility testing, bioburden testing, and bacterial endotoxin testing. The bacterial endotoxin testing segment held a major market share in 2020 due to the ongoing technological advancements in this segment.

·         Based on end user, the pharmaceutical sterility testing market is classified into compounding pharmacies, medical devices companies, pharmaceutical companies, and others. Pharmaceutical companies held the largest market share in 2020 due to the high growth of pharmaceutical and biological industries across the globe, and new drug approvals will boost the pharmaceutical sterility testing market during the forecasting period.

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Transfer Membrane Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

  

Market Synopsis

Market Research Future (MRFR) postulates that the global transfer membrane market size is projected to reach USD 0.17 billion by 2030 at a healthy CAGR of 2.1% during the forecast period (2023-2030). Transfer membrane is referred to as the collection of mechanisms which control the passage of small molecules and ions with the help of biological membranes. The surging funding by the public and private organizations in terms of life science research is highly favoring the market growth globally.

Competitive Dashboard

The global transfer membrane market players are Pall Corporation (Subsidiary of Danaher Corporation), Santa Cruz Biotechnology, Merck KGaA, GVS, Bio-Rad Laboratories, Azure Biosystems, PerkinElmer, Axiva Sichem Biotech, Advansta, Carl Roth, Atto Corporation, Macherey-Nagel, GE Healthcare, Thermo Fisher Scientific, Abcam, and others.

Market Potential and Pitfalls

Transfer membrane market is rapidly stealing the limelight during the forecast period owing to major factors such as augmenting R&D spending by the biotechnological and pharmaceutical companies, augmenting demand for polyvinylidene difluoride membrane, and increasing funding in order to support the clinical researchers. For instance, according to the Office for National Statistics, the gross domestic expenditure on R&D was Euro 33.1 billion in 2016 in the U.K.

The transfer membrane market is expanding at breakneck speed due to the raising funds for life sciences to target chronic diseases across the world. Scientific developments in terms of implementation and introduction of the latest treatment methods are further estimated to contribute to the global market throughout the assessment period. Moreover, the increased funds in R&D of pharmaceutical as well as biotechnological companies are triggering the demand for transfer membrane across the globe.

On the contrary, the dearth of skilled professionals in the healthcare sector and the high availability of alternative methods are some of the top barriers considered to vitiate the market growth throughout the appraisal period. Despite such hiccups, the rising demand for a better remedy in terms of pharmaceutical and biological advancements and a growing number of target diseases are likely to influence the market growth in the long run.

Global Transfer Membrane Market: Segmental Analysis

The global transfer membrane market has been segmented on the basis of transfer method, type, application, and end user.

By mode of type, the global transfer membrane market has been segmented into PVDF transfer membranes, nitrocellulose transfer membranes, and nylon transfer membranes. Among these, the PVDF transfer membrane is considered to occupy the largest market share owing to its advantages over nitrocellulose membranes like hydrophobicity and higher durability, rising proteomic research, and growing R&D activities by the biotechnology and pharmaceutical companies.

By mode of transfer method, the global transfer membrane market has been segmented into dry electrotransfer, semi-dry electrotransfer, tank electrotransfer, and others. Among these, the tank electrotransfer is predicted to hold the largest share in the market.

By mode of application, the global transfer membrane market has been segmented into southern blotting, western blotting, protein sequencing & amino acid analysis, northern blotting, and others. Among these, the western blotting segment is anticipated to occupy the largest market share.

By mode of end-users, the global transfer membrane market has been segmented into diagnostic laboratories, pharmaceutical & biotechnology companies, academic and research institutes, and others. Among these, the pharmaceutical and biotechnology companies are estimated to occupy the largest share in the market.

Regional Insights

Geographically, the transfer membrane market insights span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.

Considering the global scenario, the transfer membrane market is dominated by the American region due to the presence of well-established players. With technological advancements in the healthcare sector, surging funding by the government in order to support R&D, and growing demand for transfer methods in this region the market is region is estimated to propel.

The European region is estimated to occupy the second position in the global market and is likely to retain its growth in the long run. The growth is credited to the raising funds in order to support the preclinical researchers.

The Asia Pacific region is estimated to experience the fastest growth rate owing to the expanding proteomics research, the growing prevalence of target diseases in several economies in this region, and a rising scale of life sciences projects funded by the private and government bodies.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Enteral Feeding Devices Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

Market Overview

The global Enteral Feeding Devices Market size is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Segmentation:

The global enteral feeding devices market insights has been segmented on the basis of product, age group, indication, end user, and region. 

·         By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·         On the basis of age group, the market has been divided into adults and pediatrics. 

·         By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·         Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013                

 

 

Dental Consumables Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 Dental Consumables Market – Overview

The focus towards dental health has increased the demand for dental consumables significantly over the forecast period. Market focused reports related to the healthcare domain among others recently have been made available by Market Research Future which publishes reports on this market. The North America Dental Consumables Market Size is expected to grow USD 7.19 million at a CAGR of 2.70% in the forecast period 2022-2030

Increased number of dental practitioners who are utilizing dental consumables has risen considerably in the past few years. Advances in dental procedures have positively reinforced the growth trends of the dental consumables market. Increasing numbers of dental professionals around the world are expected to be instrumental in the development of the market in the coming years. Innovations related to the various areas of dentistry are significant in the expansion of the market. Dental consumables are extensively used due to an escalation in demand for minimally invasive cosmetic dental procedures, particularly in aesthetic dentistry.

Competitive Analysis

The accelerating levels of diversification in the industry, have permitted the companies to use many opportunities available in the industry. The companies in this market are acclimatizing to the state of events by employing portfolio upgrades and preserving financial liquidity. The market value has been enhanced by the constant delivery of customer value. The market competitors are creating their blueprints for corporate strategy in a way that can bring about the best results for development in the current scenario, while also alongside enhancing their product’s value. The prospect for development in the industry appears to be promising through the forecast period. The capability to fuel competitive capabilities is one of the chief causes powering their efforts in this period. Moreover, the contenders are handling the competitive environment by driving the market growth factors to their advantage.

North America Dental Consumables Market Players are

• Institut Straumann AG
• Henry Schein Inc
• Patterson Dental Supply Inc.
• Dentsply Sirona
• Kerr Corporation
• Danaher Corporation
• GC orthodontics
• Planmeca Oy
• American Orthodontics

Industry Segments

The north america dental consumables market insight is segmented on the basis of type and region. The type segment of the market comprises of dental prosthetics, dental restorative material, dental implants and dental regenerative material among others. The region-based segmentation of the dental consumable industry consists of geographical areas such as Europe, Latin America, North America, Middle East, Asia Pacific and Africa.

Detailed Regional Analysis

The regional analysis of the industry for dental consumables globally comprises of regions such as the Middle East and Africa, Europe, North America, Latin America and the Asia Pacific. The Americas region controls the main market portion and will carry on its role in guiding the market for the duration of the given forecast period due to the high acceptance of novel technologies and increased healthcare expenditures within the region. With the demand for dental consumables growing, due to the developments in dental treatments, shifting demographic trends, and a combination of other factors, the market is expanding at a good pace. Since some of the nations with better medical and healthcare facilities such as Brazil, US, and Canada. The European region is the second significant market due to the presence of well-developed economies and a sound healthcare structure. The rising skills of the oral healthcare domain across altered nations such as the Greece, U.K., Spain, and Italy among others have upgraded the possibility for development of the European region for dental consumables.

Intensification of focus on vendors from emerging markets, such as the Asia Pacific region is expected to improve the pace of market expansion. Additionally, growing demand for refining aesthetic appearance and developing awareness about dental consumables is estimated to positively add to the market development. In addition, the rise in the dental tourism for this region is expected to fuel the market expansion during the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Medical Writing Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

 

Market Overview: 

The global medical writing market has evolved exponentially with the expansion of the pharmaceutical and biotechnology industries. The use of medical writing is extensive in pharmaceutical & biotechnology companies. Moreover, the burgeoning CRO industry fosters the growth of the market. With the increase in patent expiration, the need to draft new patents is growing too, which, as a result, drives the medical writing market. Cumulatively led by these factors, the global medical writing market size valuation is expected to cross USD 5.28 Billion by 2030 at a CAGR of 10.31 % during 2022-2030.

Medical Writing Market – Competitive Analysis

Highly competitive, the medical writing market appears to be well-established, with many players forming a competitive landscape. The competitive strength of these players is highly dependent on service precision, service pricing, versatility, and service reliability. Service providers operating in the medical writing market strive to offer quality services that are based on best practices. 

Major Players: 

Global medical writing market players leading market are Freyr Solutions (US), Parexel International Corporation (US), Cactus Communications (UK), IQVIA (US), Covance Inc. (US), OMICS International (India), SIRO CLINPHARM (India), SYNCHROGENIX (US), INCLIN, (US), and Clinexa Life Sciences Pvt (Australia), among others. 

Drivers & Restraints 

Medical writing comprises scripting of diverse scientific information, preparing regulatory paperwork, and publication of documents related to drug discovery, clinical trials, and several other written communication work intended for regulatory bodies, health care providers, researchers, the general public, etc.

Medical writing requires medical knowledge and understanding of drug development and regulatory guidelines. It plays a vital role in the success of various clinical trials and research projects. It is quite challenging to handle pre-approval regulatory writing, develop a scientific platform & publication plan, promotional & educational materials, all at once by a single company. Hence, this medical writing has been the preferred model for quite some time now. 

Hiring a medical writing vendor benefits, not just the pharmaceutical companies but also to the patients and society ultimately. Resultantly the global medical writing market has been making quite a stride over the last few years. Increasing demand for regulatory paperwork in the pharmaceutical and biopharmaceutical industry is a significant driving force behind the growth of the market. Besides, rising patent expiration has been leading to increasing the demand for medical writers in recent years.

Substantial investments made in the rising numbers of research and development activities in the pharma & biotechnology industries are directly linked to the growth of the medical writing market insights. As various companies and government bodies are investing in R&D of clinical trials, the demand for clinical writing is increasing. Also, medicines are becoming more complex nowadays, and the pharmaceutical industry is becoming increasingly focused on their core competency of drug discovery.  

Consecutively, pharma companies are getting heavily reliant on outsourced partners for non-core capabilities, such as medical writing. The increased reliance in terms of strong, highly credentialed, and responsive service providers to assist with the publication, regulatory, and promotional strategies offers an exciting opportunity for the medical writing industry. However, factors such as stringent government regulatory policies are restraining the growth of the market.

 

 

Medical Writing Market – Segments

The report has been segmented into four major dynamics.

By Type                : Clinical Writing, Scientific Writing, Regulatory Writing, Disease & Drug-Related Writing, and others.

By Application     : Medical Education, Medical Journalism, Medico Marketing, and others.

By End User                     : Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), and others.

By Regions           : Americas, Europe, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Global Medical Writing Market – Regional Analysis

North America accounts for the largest share in the global medical writing market, attributing to the well-developed healthcare, pharmaceutical, and biotechnology industries. The presence of major players and pharma & biotechnology companies foster the market growth excellently. Moreover, increasing the consumption of medicines, medical devices, and other pharmaceutical products drive the growth of the regional market.

Furthermore, substantial investments made in the discovery and development of various drugs and medical products impact the market growth positively. Also, rising numbers of researches in biotechnology alongside the burgeoning CRO industry substantiate the growth of the regional market. The North American medical writing market is expected to grow at a substantial CAGR over the forecasted period.

Europe is another lucrative market for medical writing. The presence of some of the best healthcare services propels the growth of the regional market. Moreover, the growth of the healthcare industry and the expansion of various biopharmaceutical industries in the region create a massive demand for medical writing. Indeed, the resurging economy in the region is a dominant factor substantiating the market growth, increasing the healthcare and pharmaceutical industries.

The market size is increasing with the augmenting demand for CMOs and CTOs. Also, increasing government funding initiated to increase the numbers of R&D activities for the drug discoveries, provides impetus to the regional market growth. The European medical writing market is expected to grow at a considerable CAGR over the assessment period.

The medical writing market in the Asia Pacific region is emerging as a profitable market. The region has the world’s largest population and fast-developing healthcare industry. The rapidly growing pharma industry, alongside the healthcare industry, fosters the market growth in the region. Besides, the availability of skilled professional and cost-competitive services allows the region to have the edge over other regions. The APAC medical writing market is expected to grow at a rapid rate during the forecasted period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

 

 

 

DPT vaccine Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

MARKET SUMMERY

DPT stands for diphtheria, pertussis (whooping cough), and tetanus. Market Research Future (MRFR) has published and released a research report about the global DPT vaccine market size that anticipates growth for this market at 7.3% CAGR (Compound Average Growth Rate) between 2022 and 2030. In terms of market value, the worth of global DPT vaccine market has been estimated to be the USD 8342.3 million by the end of the forecast period.

The major factors facilitating the growth of the global DPT vaccine market are increasing deaths in children due to pertussis and increasing awareness about DPT vaccines. The global DPT vaccine market insights has been segmented into application, type, and lastly, region. The application-based segmentation segments this market into diphtheria, pertussis, and tetanus. By type, this market has been segmented into DPaT, DTwP, and Tdap.

Analyzing the market structure, this report offers insights about factors affecting the market growth. Estimating the market size and forecasting the revenue, this reports covers and observes the competitive developments of market players that include mergers and acquisitions, joint ventures, new product developments, research and developments (R&D), and strategic alliances.

KEY PLAYERS

The global DPT vaccine market players include

ü  Chiron Pharmaceutical Pvt Ltd (India),

ü  GSK (USA),

ü  Lanzhou Institute of Biological Products (China),

ü  Merck & Co., Inc (USA),

ü  Sanofi (France), and

ü  Wyeth (USA).

 

DTP MARKET REGIONAL ANALYSIS

The regional segmentation of the global DPT vaccine market segments the global market into regional markets namely North America, Asia Pacific, Europe, and the Middle East & Africa (MEA). North America is the largest regional market where steady market growth is expected during the forecast period. In this region, the market is growing due to the presence of many important market players in North America, especially in the USA. Other important reasons for market growth in this region are the availability of most advanced medical facilities in this region, emphasis on vaccination against DPT, established healthcare sector, and advanced R&D going on in the medical sector. After the USA, Canada and Mexico are the most important country-specific markets in this region.

Europe is the second largest regional market. The factors encouraging the market growth in this region are a high density of population, established healthcare sector, high level of technological advancement that is second only to North America, and presence of many key market players. The main country-specific markets in this region are the strongest economies known as France, Germany, and the UK, followed by the remaining countries of Europe.

The Asia Pacific is another significant market as healthcare sector is developing in countries like China and India. Advanced medical facilities and rapid technological advancement are available in Japan. The rural market in countries like China and India is still untapped which due to the high density of population can be a lucrative market once tapped into. Aided by the local government and the World Health Organization (WHO), many vaccination programs are being organized in the rural areas of countries like India. During the forecast period, the Asia Pacific region is likely to grow positively.

The MEA region has the least market share due to poor countries, lack of awareness, lack of education, low standard of medical facilities, lack of healthcare facilities, and majority governments not considering healthcare a priority.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Pacemaker Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

 

Market summery -

 

The global pacemaker market size is expected grow 4.2 billion to strike a CAGR of 3.6% over the forecast period of 2023-2030, as per the latest study report by Market Research Future (MRFR).

 

Pacemakers regularize heart rhythm by sending electric pulses to the heart and help in restoring cardiac activity. The surge in the prevalence of cardiac diseases has generated high demand for pacemakers which is driving the growth of the global pacemaker market. Atrial fibrillation, in particular, has witnessed a higher incidence rate in recent years which requires pacemakers for remediation. Increase in global geriatric population is also creating a conducive environment for the growth of the market. Atrial fibrillation and cardiac diseases are more prevalent in old patients. As per a 2018 study published in the Aging Medicine, there is 5 to 9% chance of occurrence of atrial fibrillation in patients between the age of 60-80 years and nearly 10% in patients aged over 80 years.

 

 

Technological advancements have resulted in the development of advanced pacemakers which are smaller in size and have longer battery life. Other factors aiding the growth of the market include an elevated level of awareness regarding cardiovascular diseases, improvement in reimbursement scenario, and high healthcare expenditure across the globe.

 

In recent years, various new pacemakers have received clearance from regulatory bodies which also has augmented the growth of the global pacemaker market. However, the approval and marketing if pacemakers are regulated by the US FDA which are stringent considering the degree of risk they pose to patients. Such stringent regulatory requirements might impede the growth of the market. High costs of pacemakers, risks involved in implantation procedures and risks of malfunctioning are other possible bottlenecks.

 

Competitive Landscape

Global pacemaker market players are below

ZOLL Medical Corporation, MEDICO S.p.A, Cordis, Inc., St. Jude Medical Inc., Biotronik GmbH & Co. KG, Boston Scientific Corporation, General Electric Company, Pacetronix, Medtronic Plc, Sorin Group, Edwards Lifesciences, Cook, and Vitatron are the key players in the global pacemaker market.

 

Segmentation

The global pacemaker market  has been segmented based on product type, application, implant approach, and end-user.

By product type, the global pacemaker market has been segmented into implantable and external. The implantable segment has been further segmented into single chamber, dual chamber, and biventricular.

By application, the global pacemaker market has been segmented into bradycardia, heart failure, hypertrophic cardiomyopathy, syncope, and others. The bradycardia segment has been further segmented into sinus node dysfunction and AV block.

By implant approach, the global pacemaker market has been segmented into endocardial approach and epicardial approach.

By end-user, the global pacemaker market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

 

Regional Analysis

By region, the global pacemaker market insight has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

 

The Americas account for the largest share of the global pacemaker market. Presence of a robust healthcare sector and technological advancements accelerate the growth of the market. The FDA has also been approving various novel pacemakers in the region. Moreover, the presence of various medical device manufacturers and surging cases of cardiovascular disorders support market growth in the Americas.

 

Europe follows the Americas closely and ranks second in the global pacemaker market. Growing government support in the form of R&D grants and the growing presence of key players in the region drive the market in Europe. The growing incidence rate of cardiovascular diseases and high healthcare expenditure are other factors substantiating the growth of the market.

 

APAC pacemaker market is driven by the growing prevalence of atrial fibrillation in the region. In addition, the region has emerged as a medical tourism hub which is likely to propel the growth of the market. Increasing healthcare expenditure and the presence of a large pool of cardiac patients also will have a positive impact on market growth.

 

The MEA market is likely to exhibit sluggish growth due to lack of healthcare infrastructure, lack of technical knowledge and less awareness regarding cardiac medical conditions.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America